Setting 52 Week High, Medifast Inc (NYSE:MED) Ends The Day At $161.71

Medifast Inc (NYSE:MED)

June 14th, 2018

Medifast Inc closed Thursday up 2.67%, a $4.20 increase to close on $161.71. In addition it hit a new 52 week high of $162.41. The stock continues to trade well at 304% of its 52 week low of $40.00.

MED outperformed the rest of the Consumer Staples sector which went 0.00% today.

Analysis results from 3 analysts points to the possibility that Medifast Inc might drop somewhat (-8.88%), while Finbox has calculated (with low uncertainty) a fair value price of $116.28.

Medifast Inc Info

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

All amounts in USD unless otherwise indicated

MED daily update
MED daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US News Tribune. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.

Tell us what you think